KBS_Icon_questionmark link-ico

Metabolic Surgery for Type 2 Diabetes: Evidence, Indications, Obesity Stigma & Access to Care

Park Plaza Westminster Bridge, London

10 Sep NEV-main-LondonLandscape

Metabolic Surgery for Type 2 Diabetes: Evidence, Indications and Barriers to Accessing Evidence-Based Therapies for Obesity-Related Diseases

Hosted by King's with the support of Diabetes UK

Conference Director: Professor Francesco Rubino

Program Co-Chairs: Professor Rachel Batterham, Dr. Alex Miras

Background:

Despite compelling evidence and broad professional consensus, only 0.1-2% of surgical candidates have access to metabolic and bariatric surgery worldwide. Barriers to access surgery are likely multi-factorial including insufficient awareness among healthcare providers, inadequate coverage and misconceptions about surgery, obesity, and diabetes. In this conference leading medical experts and other stakeholders will discuss current indications to surgical treatment and supporting evidence.

The program focuses also on barriers that prevent use of surgical and non-surgical therapies of obesity and related diseases, with particular regard to the role of stigma and widespread misconceptions about body weight regulation. This event is part of a road map of related educational initiatives leading to the World Congress on Interventional Therapies of Type 2 Diabetes (New York City, April 8-10, 2018) and aimed at facilitating access to care by reducing the impact of stigma and discrimination against people with diabetes and obesity.

This conference is designed to inform clinicians, policy makers, patients and the public.

Who should attend: GPs, Commissioners, Endocrinologists, Surgeons, Hospital Managers, Dietitians/Nutritionists, MPs, Members of the Media

Speakers and panel members:

Dr Francis Finucane (Ireland)

Professor Geltrude Mingrone (Italy)

Dr Stuart Flint (UK)

Professor John Moxham (UK)

Dr Noorez Hirani (UK)

Dame Jenni Murray (UK)

Dr David Hopkins (UK)

Professor Ameet Patel (UK)

Ms Nikki Joule (Diabetes UK)

Professor Francois Pattou (France)

Professor Lee Kaplan (USA)

Mr Shaw Somers (UK)

Mr Omar Khan (UK)

Mr Douglas Twenefour (Diabetes UK)

Professor Carel le Roux (Ireland)

Professor Jonathan Valabhji (UK)

Dr Barbara McGowan (UK)

 

 Learning objectives:

  • Clinical and economic evidence supporting surgical treatment of Type 2 diabetes
  • Surgery for Type 2 diabetes – how does it work?
  • Safety of metabolic surgery
  • Current NICE and global guidelines: who is surgery appropriate for?
  • Barriers to access of metabolic surgery for people with Type 2 diabetes
  • Causes of obesity: exploding the myths
  • The latest research findings on the mechanisms regulating body weight
  • The impact of stigma of obesity in healthcare and society

Agenda:

08:30-09:00 Welcome and Registration
09:00-12:45

Metabolic Surgery for Type 2 Diabetes: Evidence, Indications, Uptake and Barriers to Access

09:00-09:15

Introduction: Metabolic/Diabetes Surgery: between evidence and stigma. 

Francesco Rubino (UK)

09:15-09:30

Type 2 Diabetes: Prevalence, Costs, and Limitations of Conventional Therapies

Carel le Roux (Ireland)

09:30-09:45

Biological Evidence for Surgical Treatment of T2DM

Francois Pattou (France)
09:45-10:00

Clinical Evidence for Surgical Treatment of T2DM

Geltrude Mingrone (Italy)

10:00-10:15

Economic Evidence for Surgical Treatment of T2DM

Omar Khan (UK) 

10:15-10:45  Coffee Break
10:45-11:00

Global and National Guidelines: Indications and Model of Care

Rachel Batterham (UK)

11:00-11:15

Current Uptake in UK, EU and USA

Shaw Somers (BOMSS, UK) 

11:15-12:45 

PANEL and Audience Response:

Barriers to Access of Diabetes Surgery

Moderators: Rachel Batterham and Alex Miras

Panellists: Jonathan Valabhji, Noorez Hirani (GP/CCGs), David Hopkins (ABCD), Douglas Twenefour (Diabetes UK), Ameet Patel, John Moxham, Patient, Shaw Somers (BOMSS)

12:45-13:30 Lunch
13:30-17:00

Mini-Symposium: Are Misconceptions and Stigma of Obesity Holding Back Evidence-Based Therapies?

13:30-13:45 

Misconceptions and Stigma of Obesity

Francesco Rubino (UK) 

13:45-14:00 

Obesity: Highly Prevalent, Poorly Understood, Too Often Untreated

Rachel Batterham (UK) 

14:00-14:15

The Obesity Stigma in the Media

Stuart Flint (UK)

14:15-14:30

The Root Cause of the Stigma: A Misunderstanding of the Biology of Body Weight Regulation

Lee Kaplan (USA)

14:30-14:45

How Misconceptions and Stigma Undermine Access to Surgical Therapies of Obesity and Related Diseases

Francis Finucane (Ireland)

14:45-15:00

How Misconceptions and Stigma Undermine Access to Pharmacological Treatments of Obesity and Diabetes

Alex Miras (UK)
15:00-15:20 Coffee Break
15:20-17:00

PANEL and audience response:

Reducing Stigma and Misconceptions to Ensure Equitable Access to Evidence-Based Therapies: Proposals for A Road Map

Moderators: Rachel Batterham and Francesco Rubino

Panellists: Jonathan Valabhji, Barbara McGowan, Carel le Roux, Jenni Murray, Nikki Joule (Diabetes UK), Jessica Catchpole

 

 


Search for another event